Dr Lara Boyd
Tessellate BIO has appointed Dr Lara Boyd as CBO Tessellate BIO has appointed Dr Lara Boyd as Chief Business Officer. Lara joins...
Tessellate BIO has appointed Dr Lara Boyd as CBO Tessellate BIO has appointed Dr Lara Boyd as Chief Business Officer. Lara joins...
Commit Biologics has appointed Mikkel Wandahl Pedersen as CSO Commit Biologics has announced the appointment of Mikkel Wandahl Pedersen as...
With the rapid development of antibiotics in the 1930s, phage therapy - using viruses known as bacteriophages or phages to...
There’s no denying it; pharma is in its innovation era. The life sciences industry is already undergoing a massive revolution,...
The preclinical study, published in Cardiovascular Diabetology, found LXA4, which is known for its "calming agent" action in turning off...
Topic: Global pharmaceutical industry Statista
Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024? Yahoo Finance
Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024? Yahoo Finance
The biotech will use the funding to drive sales of its first commercial product Cytomos has announced that it has...
Mahony will continue as the UK government’s Life Sciences Investment Envoy The Department for Science, Innovation and Technology has announced...
How a global biopharma became a leader in ethical AI EY
Researchers at Karolinska Institutet have found a molecule that can both help the intestines to heal after damage and suppress...
The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles Ardena has announced the full...
The MHRA has appointed Anthony Harnden as Chair The Medicine and Healthcare products Regulatory Agency (MHRA) has appointed Anthony Harnden,...
Malaria, particularly in its severe forms, remains a global health and economic burden. It causes the deaths of more than...
The census found that 56% of people visit their GP for a UTI and 27% for thrush New research from...
The King’s Fund has appointed Siva Anandaciva as Director of Policy, Events and Partnerships The King’s Fund has appointed Siva...
AstraZeneca has announced $3.5 billion of capital investment in the United States focused on expanding the Company's research and manufacturing...